CE Geyer
Impact in
-
- HER2/EGFR in Cancer Research
- Bone health and treatments
- PARP inhibition in cancer therapy
- Cancer Treatment and Pharmacology
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 3
- HER2/EGFR in Cancer Research 3
- Colorectal Cancer Treatments and Studies 1
-
- Breast Cancer Treatment Studies 5
- Co-authors
- Adam M. Brufsky (4 shared papers)Priya Rastogi (5 shared papers)David Cameron (2 shared papers)Shaker R. Dakhil (1 shared paper)Ahmad Hussein Awada (1 shared paper)C.F. Singer (1 shared paper)Andrea F. Eisen (1 shared paper)Louis Fehrenbacher (2 shared papers)
- Journals
- Cancer Research (4 papers)Annals of Oncology (2 papers)European Journal of Cancer (1 paper)European Journal of Cancer Supplements (1 paper)Senologie - Zeitschrift für Mammadiagnostik und -therapie (1 paper)
- Partner nations
- United StatesSpainJapan
In The Last Decade
CE Geyer
9 papers receiving 71 citations
Peers
Comparison fields: 5 of 12
- Oncology 55
- Cancer Research 16
- Radiology, Nuclear Medicine and Imaging 17
- Orthopedics and Sports Medicine 4
- Pulmonary and Respiratory Medicine 15
Countries citing papers authored by CE Geyer
This map shows the geographic impact of CE Geyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CE Geyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CE Geyer more than expected).
Fields of papers citing papers by CE Geyer
This network shows the impact of papers produced by CE Geyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CE Geyer. The network helps show where CE Geyer may publish in the future.
Co-authors
The 25 scholars most cited alongside CE Geyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 29 | |
| 2 | 2011 | 16 | |
| 3 | 2011 | 14 | |
| 4 | 2011 | 6 | |
| 5 | 2011 | 3 | |
| 6 | 2008 | 2 | |
| 7 | 2020 | 2 | |
| 8 | 2015 | 1 | |
| 9 | 2021 | 1 |
About CE Geyer
CE Geyer is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 9 papers that have together received 74 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (7 papers), Breast Cancer Treatment Studies (5 papers), Cancer Treatment and Pharmacology (3 papers), HER2/EGFR in Cancer Research (3 papers), Colorectal Cancer Treatments and Studies (1 paper), Prostate Cancer Treatment and Research (1 paper), BRCA gene mutations in cancer (1 paper) and Medical Imaging Techniques and Applications (1 paper). The work is most often cited by research in Oncology (55 citations), Cancer Research (16 citations), Radiology, Nuclear Medicine and Imaging (17 citations), Orthopedics and Sports Medicine (4 citations) and Pulmonary and Respiratory Medicine (15 citations). CE Geyer has collaborated with scholars based in United States, Spain and Japan. Frequent co-authors include Adam M. Brufsky, Priya Rastogi, David Cameron, Shaker R. Dakhil, Ahmad Hussein Awada, C.F. Singer, Andrea F. Eisen, Louis Fehrenbacher, Maria Taboada and Christine E. Campbell. Their work appears in journals such as Cancer Research, Annals of Oncology, European Journal of Cancer, European Journal of Cancer Supplements and Senologie - Zeitschrift für Mammadiagnostik und -therapie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.